Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) have been given an average rating of “Hold” by the four brokerages that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $4.00.
Several analysts have recently weighed in on the company. Wall Street Zen downgraded Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a report on Saturday, April 4th. Weiss Ratings downgraded Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a report on Wednesday, May 6th.
Read Our Latest Report on BIOX
Bioceres Crop Solutions Trading Down 4.5%
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last released its quarterly earnings data on Monday, May 11th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.11). Bioceres Crop Solutions had a negative return on equity of 33.97% and a negative net margin of 92.85%.The business had revenue of $39.40 million for the quarter, compared to analyst estimates of $54.50 million. As a group, analysts anticipate that Bioceres Crop Solutions will post -0.16 earnings per share for the current fiscal year.
Institutional Trading of Bioceres Crop Solutions
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Bank of America Corp DE raised its stake in Bioceres Crop Solutions by 186.8% during the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after acquiring an additional 3,735 shares during the last quarter. Jones Financial Companies Lllp raised its stake in Bioceres Crop Solutions by 3,535.8% during the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock valued at $25,000 after acquiring an additional 5,339 shares during the last quarter. PDT Partners LLC raised its stake in Bioceres Crop Solutions by 58.9% during the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock valued at $126,000 after acquiring an additional 10,449 shares during the last quarter. Virtu Financial LLC purchased a new stake in Bioceres Crop Solutions during the 3rd quarter valued at approximately $40,000. Finally, Invesco Ltd. purchased a new stake in Bioceres Crop Solutions during the 4th quarter valued at approximately $45,000. 17.68% of the stock is owned by hedge funds and other institutional investors.
About Bioceres Crop Solutions
Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.
Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.
Featured Stories
- Five stocks we like better than Bioceres Crop Solutions
- MarketBeat Week in Review – 05/11 – 05/15
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
